Serum concentrations of caffeine, metamizol, debrisoquine, sulfamethazine and their metabolites in diabetics before and during insulin therapy;Vergleich der Serumkonzentration von Coffein, 4-Monomethylaminoantipyrin, Sulfamethazin and Debrisoquin nach oraler Verabreichung dieser Substanzen als Cocktail bei Typ-II-Diabetikern vor und nach Umstellung auf Insulin

Pharmazie

Volumn 51, Issue 10, 1996, Pages 750-753

  Lautenschlager, M T ^a,b   Viktor, S ^a   Muller U A ^a   Hoffmann, A ^a  

^a FRIEDRICH SCHILLER UNIVERSITY JENA   (Germany)

^b NONE   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ACYLTRANSFERASE; CAFFEINE; CIMETIDINE; CYTOCHROME P450; DEBRISOQUINE; DIPYRONE; DRUG METABOLITE; GLIBENCLAMIDE; INSULIN; LIVER ENZYME; NIFEDIPINE; PHENOBARBITAL; PROPRANOLOL; SULFADIMIDINE; TRIAMTERENE;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIABETES MELLITUS; DRUG BLOOD LEVEL; DRUG DETERMINATION; DRUG URINE LEVEL; ENZYME INDUCTION; FEMALE; HUMAN; HYPERTENSION; LIVER DISEASE; LIVER METABOLISM; MALE; ORAL DRUG ADMINISTRATION;

ADULT; AGED; ANTI-INFECTIVE AGENTS; CAFFEINE; CENTRAL NERVOUS SYSTEM STIMULANTS; CYTOCHROME P-450 ENZYME SYSTEM; DEBRISOQUIN; DIABETES MELLITUS, TYPE 2; DIPYRONE; DRUG COMBINATIONS; FEMALE; HUMANS; HYPOGLYCEMIC AGENTS; INSULIN; ISOENZYMES; MALE; MIDDLE AGED; PYRAZOLONES; SULFAMETHAZINE; SYMPATHOLYTICS;

EID: 0029963439     PISSN: 00317144     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Wilson, J. H. P.: Liver Annual 5, 503 (1986)
2. Eichelbaum, M.; Bertilsson, L.; Säwe, J.; Zekorn, C.: Clin. Pharmacol. Ther. 31, 184 (1982)
3. Weber, W. W.: Federation Proc. 43, 2332 (1984)
4. Henschel, L.; Hoffmann, A.: Z. Gastroenterol. 29, 645 (1991)
5. Johannson, I.; Ekström, G.; Scholte, B.; Puzycki, D.; Jörnvall, H.; Ingelmann-Sundberg, M.: Biochemistry 27, 1925 (1988)
6. Thomas, H.; Schladt, L.; Knehr, M.; Oesch, F.: Biochem. Pharmacol. 28, 4291 (1989)
7. Hong, J.; Pan, J.; Gonzalez, F. J.; Gelboin, H. V.; Chung, S. Y.: Biochem. Biophys. Res. Commun. 142, 1077 (1987)
8. Favreau, L. V.; Malchoff, D. M.; Mole, J. E.; Schenkmann, J. B.: J. Biol. Chem. 262, 14319 (1987)
9. Henschel, L.: Diss. Univ. Greifswald 1990
10. Watkins III, J. B.; Sanders, R. A.; in: Siegers, C. P.; Watkins III, J. B. (eds.): Biliary Excretion of Drugs and other Chemicals (Progress in Pharmacology and Clinical Pharmacology, Vol. 8/4), S. 475, G. Fischer-Verlag, Stuttgart/New York 1991
11. Yamazoe, Y.; Murayama, N.; Shimada, M.; Yamauchi, K.; Kato, R.: Arch. Biochem. Biophys. 268, 567 (1989)
12. Shimeno, H.; Toda, A.; Ogata, S.; Nagamatsu, A.: Drug Metab. Dispos. 19, 291 (1991)
13. Oltmanns, D.; Dennin, D. E.; Rentz, R.; Siegers, C. P.: Z. Gastroenterol. 22, 598 (1984)
14. Salmela, P. I.; Sotaniemi, E. A., Pelkonen, R. O.: Diabetes 29, 788 (1980)
15. Kraul, H.; Truckenbrodt, J.; Huster, A.; Töpfer, R.; Hoffmann, A.: Eur. J. Clin. Pharmacol. 42, 475 (1991)
16. Bratton, A. C.; Marshall Jr., E. K.; J. Biol. Chem. 128, 537 (1939)
17. Evans, D. A. P.: J. Med. Genet. 6, 405 (1969)
18. Evans, D. A. P.; Magoub, A.; Sloan, T. P.: J. Med. Genet. 17, 102 (1980)